17.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Viridian Therapeutics Inc Borsa (VRDN) Ultime notizie
What drives Viridian Therapeutics Inc. stock priceFree Stock Movement Tracking - PrintWeekIndia
Viridian Therapeutics Inc. Stock Analysis and ForecastTremendous return rates - Autocar Professional
What analysts say about Viridian Therapeutics Inc. stockLightning-fast growth - PrintWeekIndia
What makes Viridian Therapeutics Inc. stock price move sharplyProfit Focused Trade Alerts - Newser
How Viridian Therapeutics Inc. stock performs during market volatilityMarket Ready Callouts - Newser
Is Viridian Therapeutics Inc. a good long term investmentConsistently high returns - Autocar Professional
Viridian Therapeutics’ Veligrotug Shows Durable Proptosis Response in Phase 3 TED Trial - MSN
Why Viridian Therapeutics Inc. stock attracts strong analyst attentionBreakout Level Watch - Newser
Teacher Retirement System of Texas Decreases Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
(VRDN) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Principal Financial Group Inc. Acquires 30,392 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey
Evercore Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Cuts Target Price to $38 - 富途牛牛
Amalgamated Bank Has $34,000 Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
Evercore ISI Lowers Viridian Therapeutics Price Target to $38 - AInvest
Viridian Therapeutics Sees Relative Strength Rating Improve To 79 - MSN
(VRDN) Investment Analysis - news.stocktradersdaily.com
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Viridian Therapeutics: Fueling R&D Breakthroughs Through Strategic Equity Incentives - AInvest
Is Viridian Therapeutics (NASDAQ:VRDN) A Risky Investment? - simplywall.st
(VRDN) On The My Stocks Page - news.stocktradersdaily.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):